University of Cambridge > > Dementia Journal Club > Neuroinflammation and gut microbiota in AD progression

Neuroinflammation and gut microbiota in AD progression

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Veronica Kane Dickson.

Nathan Zaccai of the CIMR will be guiding us through the recent research investigating the impact of gut microbiota on neuroinflammation and AD pathogenesis, which has led to approval of oligomannate as a treatment for mild to moderate AD in China.

Wang, X., Sun, G., Feng, T. et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Res 29, 787–803 (2019) doi:10.1038/s41422-019-0216-x

This talk is part of the Dementia Journal Club series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity